128 related articles for article (PubMed ID: 38537446)
1. Berberine alleviates inflammation in polycystic ovary syndrome by inhibiting hyaluronan synthase 2 expression.
He S; Li H; Zhang Q; Zhao W; Li W; Dai C; Li B; Cheng J; Wu S; Zhou Z; Yang J; Li S
Phytomedicine; 2024 Jun; 128():155456. PubMed ID: 38537446
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin Alleviates Inflammation, Insulin Resistance, and Reproductive Abnormalities in Mice with Polycystic Ovary Syndrome via the TLR4-NF-κB Signaling Pathway.
Liu F; Wang X; Zhao M; Zhang K; Li C; Lin H; Xu L
Discov Med; 2024 May; 36(184):946-958. PubMed ID: 38798254
[TBL] [Abstract][Full Text] [Related]
3. Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis.
Shen HR; Xu X; Li XL
Reprod Biol Endocrinol; 2021 Jan; 19(1):3. PubMed ID: 33407557
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome.
Li Y; Zheng Q; Sun D; Cui X; Chen S; Bulbul A; Liu S; Yan Q
J Cell Physiol; 2019 May; 234(5):7435-7447. PubMed ID: 30580448
[TBL] [Abstract][Full Text] [Related]
5. IL-15 Participates in the Pathogenesis of Polycystic Ovary Syndrome by Affecting the Activity of Granulosa Cells.
Liu Y; Li Z; Wang Y; Cai Q; Liu H; Xu C; Zhang F
Front Endocrinol (Lausanne); 2022; 13():787876. PubMed ID: 35250857
[TBL] [Abstract][Full Text] [Related]
6. PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA-induced granulosa cell apoptosis in vitro.
Ji X; Ye Y; Wang L; Liu S; Dong X
Drug Dev Res; 2023 Apr; 84(2):226-237. PubMed ID: 36621953
[TBL] [Abstract][Full Text] [Related]
7. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
8. The Upregulation of HAS2-AS1 Relates to the Granulosa Cell Dysfunction by Repressing TGF-β Signaling and Upregulating HAS2.
Xiang Y; Yu G; Song Y; Li Y; Cheng L; Li P; Zhang L; Wang M; Tan L
Mol Cell Biol; 2022 Sep; 42(9):e0010722. PubMed ID: 35938797
[TBL] [Abstract][Full Text] [Related]
9. Chitosan oligosaccharide improves ovarian granulosa cells inflammation and oxidative stress in patients with polycystic ovary syndrome.
Xie Q; Hong W; Li Y; Ling S; Zhou Z; Dai Y; Wu W; Weng R; Zhong Z; Tan J; Zheng Y
Front Immunol; 2023; 14():1086232. PubMed ID: 36936973
[TBL] [Abstract][Full Text] [Related]
10. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
[TBL] [Abstract][Full Text] [Related]
11. Interlukin-22 improves ovarian function in polycystic ovary syndrome independent of metabolic regulation: a mouse-based experimental study.
Chen W; Liao B; Yun C; Zhao M; Pang Y
J Ovarian Res; 2024 May; 17(1):100. PubMed ID: 38734641
[TBL] [Abstract][Full Text] [Related]
12. Exploring the efficacy and mechanism of Bailing capsule to improve polycystic ovary syndrome in mice based on intestinal-derived LPS-TLR4 pathway.
Guan HR; Li B; Zhang ZH; Wu HS; Wang N; Chen XF; Zhou CL; Bian XR; Li L; Xu WF; He XL; Dong YJ; Jiang NH; Su J; Lv GY; Chen SH
J Ethnopharmacol; 2024 Sep; 331():118274. PubMed ID: 38697410
[TBL] [Abstract][Full Text] [Related]
13. The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome.
Kuang H; Duan Y; Li D; Xu Y; Ai W; Li W; Wang Y; Liu S; Li M; Liu X; Shao M
PLoS One; 2020; 15(8):e0235404. PubMed ID: 32785222
[TBL] [Abstract][Full Text] [Related]
14. PPAR-α inhibits DHEA-induced ferroptosis in granulosa cells through upregulation of FADS2.
Liu Y; Ni F; Huang J; Hu Y; Wang J; Wang X; Du X; Jiang H
Biochem Biophys Res Commun; 2024 Jun; 715():150005. PubMed ID: 38678785
[TBL] [Abstract][Full Text] [Related]
15. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
16. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
[TBL] [Abstract][Full Text] [Related]
17. Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome.
Wang M; Zhao D; Xu L; Guo W; Nie L; Lei Y; Long Y; Liu M; Wang Y; Zhang X; Zhang L; Li H; Zhang J; Yuan D; Yue L
Metabolism; 2019 May; 94():47-58. PubMed ID: 30768966
[TBL] [Abstract][Full Text] [Related]
18. Abnormality of Klotho Signaling Is Involved in Polycystic Ovary Syndrome.
Mao Z; Fan L; Yu Q; Luo S; Wu X; Tang J; Kang G; Tang L
Reprod Sci; 2018 Mar; 25(3):372-383. PubMed ID: 28673204
[TBL] [Abstract][Full Text] [Related]
19. The Release of Peripheral Immune Inflammatory Cytokines Promote an Inflammatory Cascade in PCOS Patients
Liu Y; Liu H; Li Z; Fan H; Yan X; Liu X; Xuan J; Feng D; Wei X
Front Immunol; 2021; 12():685724. PubMed ID: 34079559
[TBL] [Abstract][Full Text] [Related]
20. Increased pro-inflammatory cytokines in ovary and effect of γ-linolenic acid on adipose tissue inflammation in a polycystic ovary syndrome model.
Prabhu YD; Borthakur A; A G S; Vellingiri B; Valsala Gopalakrishnan A
J Reprod Immunol; 2021 Aug; 146():103345. PubMed ID: 34116484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
